In the EMPA-KIDNEY trial, empagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, had positive cardiorenal effects in patients with chronic kidney disease who were at risk for disease pr…
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart-failure admission among high-risk patients. However, most patients with valvular heart disease, including those undergoing…
A 56-year-old man was transferred to a burn center for management of pavement burns on his feet that had occurred during a heat wave.
Patients with severe aortic stenosis and a small aortic annulus are at risk for impaired valvular hemodynamic performance and associated adverse cardiovascular clinical outcomes after…
Patients with severe aortic stenosis and a small aortic annulus are at risk for impaired valvular hemodynamic performance and associated adverse cardiovascular clinical outcomes after…
The dismantling of foreign-assistance efforts has already had, and will continue to have, severe effects on vulnerable populations globally. But it also has implications for…
It is worth examining the efforts to discover SARS-CoV-2’s origins. But regardless of the origins of the virus, the global community can take steps to…
A 46-year-old woman with a history of migraine with visual aura presented with a 3-hour history of headache, as well as weakness and numbness in…
A patient with poorly controlled HIV infection was found to have two different strains of Treponema pallidum. Careful evaluation showed evidence for recombination between these…
Tecovirimat is available for the treatment of mpox (formerly known as monkeypox) in Europe and the United States, on the basis of findings from efficacy…
The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft outco…
